![]() |
市場調査レポート
商品コード
1619012
高価値植物化合物の世界市場:原料・タイプ・用途別の予測 (~2032年)Global High Value Plant Compound Market Research Report Information by Source, Type, Application, Forecast Till 2032 |
||||||
|
高価値植物化合物の世界市場:原料・タイプ・用途別の予測 (~2032年) |
出版日: 2024年12月02日
発行: Market Research Future
ページ情報: 英文 117 Pages
納期: 即納可能
![]() |
世界の高価値植物化合物の市場規模は、2023年の165億3,670万米ドルから、予測期間中は11.69%のCAGRで推移し、2032年には447億2,470万米ドルの規模に成長すると予測されています。
植物由来のサプリメントや栄養補助食品の需要は、世界の健康とウェルネスの動向によって牽引されています。総合的な健康を促進し、健康問題に対処する栄養補助食品は、高品質の植物化合物を用いて調製されます。医薬品、栄養補助食品、化粧品、食品・飲料を含む様々な産業における天然有機製品への需要が、世界の高価値植物化合物市場の主な促進要因となっています。これらの化合物の健康上の利点に対する消費者の意識が高まり、合成品よりも天然品を好む傾向が強まった結果、市場は成長を遂げました。一方で、市場には抽出プロセスの高コスト、規制上の障害、植物原料の持続可能な調達に関する懸念など、さまざま課題があります。市場参入企業は、抽出技術の技術的進歩や研究開発活動への注力の結果、有利な機会を得るものと予測されています。
地域別の展望
北米地域は2022年に最大の規模を示し、市場規模は43億米ドルでした。2022年から2032年にかけてはCAGR 11.21%で大幅な成長を示すと予測されています。自然療法、栄養補助食品、ウェルネス製品への関心の高まりが、北米における高価値植物化合物市場の拡大を促す主な要因となっています。
欧州は2022年に34億米ドルの規模を示し、予測期間中は10.74%のCAGRで一貫した成長を示すと予測されています。市場の拡大は、特に化粧品や栄養補助食品において、欧州の消費者が高価値植物化合物を採用したためです。
アジア太平洋地域は2022年に67億米ドルの市場規模を示し、予測期間中はCAGR 12.02%で成長すると予測されています。この地域の堅調なCAGRは、製薬業界や食品業界でハーブ療法やアーユルヴェーダ療法が広く採用されていること、インドや中国などの国でこれらの療法の人気が高まっていることなどに起因しています。
当レポートでは、世界の高価値植物化合物の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Global High Value Plant Compound Market Research Report Information by Source (Leaves, Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, Other Sources), Type (Phenylpropanoids, Alkaloids, Terpenoids, Polyketides), Application (Pharmaceuticals, Cosmetics, Food & Beverages, Dietary Supplements, Others, Forecast Till 2032
In 2023, the High Value Plant Compound Market Size was estimated to be USD 16,536.70 million. The Global High Value Plant Compound industry is anticipated to experience a compound annual growth rate (CAGR) of 11.69% from 2024 to 2032, resulting in a total value of USD 44,724.70 million.
The demand for plant-based supplements and nutraceuticals is being driven by the global health and wellness trend. Dietary supplements that promote overall health and address health issues are prepared using high-quality plant compounds. The demand for natural and organic products in a variety of industries, including pharmaceuticals, nutraceuticals, cosmetics, and food and beverages, is the primary driver of the global high-value plant compounds market. The market has experienced growth as a result of the increasing consumer awareness of the health benefits of these compounds and the increasing preference for natural products over synthetic ones. Nevertheless, the market is confronted with a variety of obstacles, including the high cost of extraction processes, regulatory obstacles, and concerns regarding the sustainable procurement of plant materials. It is anticipated that market participants will experience lucrative opportunities as a result of technological advancements in extraction techniques and a focus on research and development activities.
Market segment insights
Table 1 illustrates a substantial upward trajectory in the global market for high-value plant compounds from 2022 to 2032. The market, which was valued at USD 14,919.4 million in 2022, is expected to experience a Compound Annual Growth Rate (CAGR) of 11.7% from 2023 to 2032, culminating in a spectacular USD 44,724.7 million in 2032. These compounds, which are derived from a variety of plant sources, are of significant value because they are used in industries such as pharmaceuticals, cosmetics, and food.
Leaves comprise the greatest portion of this market among the various plant sources. Leaves generated USD 4,730.6 million in 2022, and this sector is anticipated to expand at a compound annual growth rate (CAGR) of 11.8%. The substantial increase in the leaves category can be attributed to the growing demand for herbal and botanical constituents in healthcare and wellness products. Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, and Other Sources are also significant contributors to this market, with CAGRs of 12.2%, 10.7%, 12.0%, and 11.5%, respectively.
One of the fastest-growing segments in the market is phenylpropanoids, including curcumin and resveratrol, with a compound annual growth rate (CAGR) of 11.7%. The antioxidant and anti-inflammatory properties of these compounds have made them a popular ingredient in dietary supplements and cosmetic products. Alkaloids and terpenoids are also positioned for significant growth, with anticipated compound annual growth rates (CAGRs) of 11.8% and 11.6%, respectively.
Regional Perspectives
In 2022, North America was the greatest market, with a market valuation of $4.3 billion. between 2022 and 2032, the region experienced substantial growth, with a Compound Annual Growth Rate (CAGR) of 11.21%. The burgeoning interest in natural remedies, dietary supplements, and wellness products is the primary factor driving the expansion of the high-value plant compounds market in North America.
Europe, which had a market value of $3.4 billion in 2022, exhibited a compound annual growth rate (CAGR) of 10.74% during the same period, indicating consistent growth. The market has expanded because of the adoption of high-value plant compounds by European consumers, particularly in cosmetics and dietary supplements.
The market value of $6.7 billion in 2022 was achieved by the Asia-Pacific region, which exhibited the maximum CAGR at 12.02% during the same period. The region's robust CAGR can be attributed to the extensive adoption of herbal and Ayurvedic remedies in the pharmaceutical and food industries, as well as the increasing popularity of these remedies in countries such as India and China.
Merck KGaA, MedChemExpress, Selleck Chemicals, Biosynth, Tokyo Chemical Industry, Advion, Inc, Alkaloids Corporation, C-Squared Pharma S.a R.L., Linnea SA, and Inga Pharmaceuticals are among the key companies in the High Value Plant Compound market.